You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
中國再生醫學(08158.HK)擬折讓約23.08%1供2發售約17.59億股 淨籌約3.47億港元
格隆匯 02-06 06:18

格隆匯2月6日丨中國再生醫學(08158.HK)公佈,擬按每持有1股股份獲發2股發售股份基準公開發售約17.59億股發售股份。發售股份總數相當於已發行股份數目的200%;及經擴大後已發行股份數目的66.67%。

公告顯示,發售股份認購價每股0.2港元,收市價每股0.26港元折讓約23.08%。

公告稱,所得款項淨額約為3.47億港元。公司計劃將(i)約1.5億港元用作償還集團的未償還負債;及(ii)約1.97億港元用作集團的一般營運資金。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account